2.4.1.165: N-acetylneuraminylgalactosylglucosylceramide beta-1,4-N-acetylgalactosaminyltransferase
This is an abbreviated version!
For detailed information about N-acetylneuraminylgalactosylglucosylceramide beta-1,4-N-acetylgalactosaminyltransferase, go to the full flat file.
Reaction
Synonyms
acetylgalactosaminyltransferase, uridine diphosphoacetylgalactosamine-acetylneuraminyl(alpha2-->3)galactosyl(beta1-->4)glucosyl beta1-->4-, beta-1,4-N-acetylgalactosyltransferase II, beta4GalNAc-T, beta4GalNAcT-II, CT GalNAc transferase, cytotoxic T cell GalNAc transferase, Galgt2, More, Sd(alpha) beta4GalNAcT-II, Sda-beta-1,4-N-acetylgalactosaminyltransferase, Sda-beta-GalNAc-transferase, UDP-GalNAc:beta1,4-N-acetylgalactosaminyltransferase
ECTree
Advanced search results
Disease
Disease on EC 2.4.1.165 - N-acetylneuraminylgalactosylglucosylceramide beta-1,4-N-acetylgalactosaminyltransferase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Carcinoma
Molecular cloning of the human beta1,4 N-acetylgalactosaminyltransferase responsible for the biosynthesis of the Sd(a) histo-blood group antigen: the sequence predicts a very long cytoplasmic domain.
Colonic Neoplasms
Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon.
Colorectal Neoplasms
Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon.
Gastrointestinal Neoplasms
Expression of the human Sd(a) beta-1,4-N-acetylgalactosaminyltransferase II gene is dependent on the promoter methylation status.
Leukemia
Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact.
Muscular Diseases
Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.
Muscular Dystrophies
B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.
Muscular Dystrophies
Comparative Proteomic Profiling of Dystroglycan-Associated Proteins in Wild Type, mdx, and Galgt2 Transgenic Mouse Skeletal Muscle.
Muscular Dystrophies
Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
Muscular Dystrophies
Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.
Muscular Dystrophies
Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.
Muscular Dystrophies
Overexpression of the CT GalNAc transferase inhibits muscular dystrophy in a cleavage-resistant dystroglycan mutant mouse.
Muscular Dystrophies
Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.
Muscular Dystrophies
Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism.
Muscular Dystrophies
Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of GALGT2 Expression and GALGT2-Dependent Muscle and Neuromuscular Phenotypes.
Muscular Dystrophies
The synaptic CT carbohydrate modulates binding and expression of extracellular matrix proteins in skeletal muscle: partial dependence on utrophin.
Muscular Dystrophies
Vascular Delivery of rAAVrh74.MCK.GALGT2 to the Gastrocnemius Muscle of the Rhesus Macaque Stimulates the Expression of Dystrophin and Laminin ?2 Surrogates.
Muscular Dystrophies, Limb-Girdle
B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.
Muscular Dystrophies, Limb-Girdle
Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.
Muscular Dystrophy, Duchenne
Congenital muscular dystrophies involving the O-mannose pathway.
Muscular Dystrophy, Duchenne
Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.
Muscular Dystrophy, Duchenne
Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice.
Muscular Dystrophy, Duchenne
The modulation of skeletal muscle glycosylation as a potential therapeutic intervention in muscular dystrophies.
Stomach Neoplasms
Expression of the human Sd(a) beta-1,4-N-acetylgalactosaminyltransferase II gene is dependent on the promoter methylation status.
html completed